
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease
Zhiwen Fan, Xinyue Sun, Xuelian Chen, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100805-100805
Open Access | Times Cited: 24
Zhiwen Fan, Xinyue Sun, Xuelian Chen, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100805-100805
Open Access | Times Cited: 24
Showing 24 citing articles:
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism
Anna Castells‐Nobau, José María Moreno‐Navarrete, Lisset de la Vega-Correa, et al.
Gut (2024), pp. gutjnl-332602
Closed Access | Times Cited: 5
Anna Castells‐Nobau, José María Moreno‐Navarrete, Lisset de la Vega-Correa, et al.
Gut (2024), pp. gutjnl-332602
Closed Access | Times Cited: 5
Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis
Xiaoyan Wu, Yuzhou Shen, Yufei Meng, et al.
Life Sciences (2024) Vol. 341, pp. 122498-122498
Closed Access | Times Cited: 4
Xiaoyan Wu, Yuzhou Shen, Yufei Meng, et al.
Life Sciences (2024) Vol. 341, pp. 122498-122498
Closed Access | Times Cited: 4
RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway
Hanlin Shi, Xiaohong Duan, Jingcheng Dong, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117963-117963
Closed Access | Times Cited: 4
Hanlin Shi, Xiaohong Duan, Jingcheng Dong, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117963-117963
Closed Access | Times Cited: 4
Longitudinal cytokine and multi-modal health data of an extremely severe ME/CFS patient with HSD reveals insights into immunopathology, and disease severity
Fereshteh Jahanbani, Justin Sing, Rajan Douglas Maynard, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Fereshteh Jahanbani, Justin Sing, Rajan Douglas Maynard, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Eosinophils Enhance Granuloma-Mediated Control of Persistent Salmonella Infection
Denise M. Monack, Daniel Butler, Blanda Di Luccia, et al.
Research Square (Research Square) (2025)
Closed Access
Denise M. Monack, Daniel Butler, Blanda Di Luccia, et al.
Research Square (Research Square) (2025)
Closed Access
The Impact of Steatotic Liver Disease on Cytokine and Chemokine Kinetics During Sepsis
Nina Vrsaljko, Leona Radmanić, Snježana Židovec Lepej, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2226-2226
Open Access
Nina Vrsaljko, Leona Radmanić, Snježana Židovec Lepej, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2226-2226
Open Access
Knockout of Trpc6 attenuates T2DM-induced liver injury and inflammation by inhibiting CN-NFAT2-NLRP3 signalling in mice
Yan Liu, Yinglin Fu, Guohang Wang, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155894-155894
Closed Access
Yan Liu, Yinglin Fu, Guohang Wang, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155894-155894
Closed Access
CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
Raanan Greenman, Chris J. Weston
Cells (2025) Vol. 14, Iss. 2, pp. 105-105
Open Access
Raanan Greenman, Chris J. Weston
Cells (2025) Vol. 14, Iss. 2, pp. 105-105
Open Access
The C C motif chemokine ligand 11 contributes to alcoholic liver disease
Jichen Li, Ben Wang, S.F. Wang, et al.
Life Sciences (2025) Vol. 363, pp. 123409-123409
Closed Access
Jichen Li, Ben Wang, S.F. Wang, et al.
Life Sciences (2025) Vol. 363, pp. 123409-123409
Closed Access
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma
Na Qiang, Junjie Ao, Masato Nakamura, et al.
Biochemical Pharmacology (2025), pp. 116829-116829
Closed Access
Na Qiang, Junjie Ao, Masato Nakamura, et al.
Biochemical Pharmacology (2025), pp. 116829-116829
Closed Access
Interferon regulatory factor 1 contributes to metabolic dysfunction associated steatotic liver disease
Xinyue Sun, Zhen Yang, Min Li, et al.
Life Sciences (2025), pp. 123575-123575
Closed Access
Xinyue Sun, Zhen Yang, Min Li, et al.
Life Sciences (2025), pp. 123575-123575
Closed Access
C-C motif chemokines ligand 7 contributes to metabolic dysfunction-associated steatotic liver disease by enabling redox-sensitive induction of hypermethylated in cancer 1
Xinyue Sun, Jinge Wu, Heng Lv, et al.
Metabolism (2025), pp. 156242-156242
Closed Access
Xinyue Sun, Jinge Wu, Heng Lv, et al.
Metabolism (2025), pp. 156242-156242
Closed Access
Targeting leptin/CCL3-CCL4 axes in NAFLD/MAFLD: a novel role for BPF in counteracting thalamic inflammation and white matter degeneration
Antonio Cardamone, Anna Rita Coppoletta, Roberta Macrì, et al.
Pharmacological Research (2024) Vol. 209, pp. 107417-107417
Open Access | Times Cited: 3
Antonio Cardamone, Anna Rita Coppoletta, Roberta Macrì, et al.
Pharmacological Research (2024) Vol. 209, pp. 107417-107417
Open Access | Times Cited: 3
TRIB1 regulates liver regeneration by antagonizing the NRF2-mediated antioxidant response
Xinyue Sun, Shuai Wang, Xiulian Miao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 6
Xinyue Sun, Shuai Wang, Xiulian Miao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 6
Grb2-related adaptor protein GRAP is a novel regulator of liver fibrosis
Xiaoyan Wu, Yuwen Zhu, Yan Guo, et al.
Life Sciences (2023) Vol. 327, pp. 121861-121861
Closed Access | Times Cited: 4
Xiaoyan Wu, Yuwen Zhu, Yan Guo, et al.
Life Sciences (2023) Vol. 327, pp. 121861-121861
Closed Access | Times Cited: 4
SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis
Huimin Liu, Linbo Yue, Wenxuan Hong, et al.
Life Sciences (2024) Vol. 347, pp. 122605-122605
Closed Access | Times Cited: 1
Huimin Liu, Linbo Yue, Wenxuan Hong, et al.
Life Sciences (2024) Vol. 347, pp. 122605-122605
Closed Access | Times Cited: 1
Causal effects of systemic inflammatory proteins on Guillain-Barre Syndrome: insights from genome-wide Mendelian randomization, single-cell RNA sequencing analysis, and network pharmacology
Jingwen Liu, Renbing Pan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Jingwen Liu, Renbing Pan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Phosphatidic acid-enabled MKL1 contributes to liver regeneration: Translational implication in liver failure
Jiawen Zhou, Xinyue Sun, Xuelian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 256-272
Open Access | Times Cited: 2
Jiawen Zhou, Xinyue Sun, Xuelian Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 256-272
Open Access | Times Cited: 2
The chromatin remodeling protein BRG1 contributes to liver ischemia-reperfusion injury by regulating NOXA expression
Nan Li, Hong Liu, Yujia Xue, et al.
Life Sciences (2023) Vol. 334, pp. 122235-122235
Closed Access | Times Cited: 2
Nan Li, Hong Liu, Yujia Xue, et al.
Life Sciences (2023) Vol. 334, pp. 122235-122235
Closed Access | Times Cited: 2
Ablation of histone methyltransferase Suv39h2 in hepatocytes attenuates NASH in mice
Shiqiang Wu, Wenjing Ren, Jiameng Hong, et al.
Life Sciences (2024) Vol. 343, pp. 122524-122524
Closed Access
Shiqiang Wu, Wenjing Ren, Jiameng Hong, et al.
Life Sciences (2024) Vol. 343, pp. 122524-122524
Closed Access
Redox-sensitive epigenetic activation of SUV39H1 contributes to liver ischemia-reperfusion injury
Zilong Li, Jichen Li, Meng Wu, et al.
Redox Biology (2024) Vol. 78, pp. 103414-103414
Open Access
Zilong Li, Jichen Li, Meng Wu, et al.
Redox Biology (2024) Vol. 78, pp. 103414-103414
Open Access
Ubiquitin specific peptidase 47 contributes to liver regeneration
Yuwen Zhu, Yan Guo, Hong Liu, et al.
Life Sciences (2023) Vol. 329, pp. 121967-121967
Closed Access
Yuwen Zhu, Yan Guo, Hong Liu, et al.
Life Sciences (2023) Vol. 329, pp. 121967-121967
Closed Access
Targeting the chromatin remodeling protein BRG1 in liver fibrosis: Mechanism and translational potential
Yuwen Zhu, Yan Guo, Yujia Xue, et al.
Life Sciences (2023) Vol. 336, pp. 122221-122221
Closed Access
Yuwen Zhu, Yan Guo, Yujia Xue, et al.
Life Sciences (2023) Vol. 336, pp. 122221-122221
Closed Access